ะกัะฐัะธััะธะบะฐ
ะัะตะณะพ ะฟัะฑะปะธะบะฐัะธะน
36
ะัะตะณะพ ัะธัะธัะพะฒะฐะฝะธะน
96
ะฆะธัะธัะพะฒะฐะฝะธะน ะฝะฐ ะฟัะฑะปะธะบะฐัะธั
2.67
ะกัะตะดะฝะตะต ัะธัะปะพ ะฟัะฑะปะธะบะฐัะธะน ะฒ ะณะพะด
9
ะกัะตะดะฝะตะต ัะธัะปะพ ัะพะฐะฒัะพัะพะฒ
4.47
ะะพะดั ะฟัะฑะปะธะบะฐัะธะน
2023-2026 (4 ะณะพะดะฐ)
h-index
5
i10-index
2
m-index
1.25
o-index
8
g-index
7
w-index
1
ะะฟะธัะฐะฝะธะต ะผะตััะธะบ
h-index
ะฃััะฝัะน ะธะผะตะตั ะธะฝะดะตะบั h, ะตัะปะธ h ะธะท ะตะณะพ N ััะฐัะตะน ัะธัะธัััััั ะบะฐะบ ะผะธะฝะธะผัะผ h ัะฐะท ะบะฐะถะดะฐั, ะฒ ัะพ ะฒัะตะผั ะบะฐะบ ะพััะฐะฒัะธะตัั (N - h) ััะฐัะตะน ัะธัะธัััััั ะฝะต ะฑะพะปะตะต ัะตะผ h ัะฐะท ะบะฐะถะดะฐั.
i10-index
ะงะธัะปะพ ััะฐัะตะน ะฐะฒัะพัะฐ, ะฟะพะปััะธะฒัะธั
ะฝะต ะผะตะฝะตะต 10 ัััะปะพะบ ะบะฐะถะดะฐั.
m-index
m-ะธะฝะดะตะบั ััะตะฝะพะณะพ ัะธัะปะตะฝะฝะพ ัะฐะฒะตะฝ ะพัะฝะพัะตะฝะธั ะตะณะพ h-ะธะฝะดะตะบัะฐ ะบ ะบะพะปะธัะตััะฒั ะปะตั, ะฟัะพัะตะดัะธั
ั ะผะพะผะตะฝัะฐ ะฟะตัะฒะพะน ะฟัะฑะปะธะบะฐัะธะธ.
o-index
ะกัะตะดะฝะตะต ะณะตะพะผะตััะธัะตัะบะพะต h-ะธะฝะดะตะบัะฐ ะธ ัะธัะปะฐ ัะธัะธัะพะฒะฐะฝะธะน ะฝะฐะธะฑะพะปะตะต ัะธัะธััะตะผะพะน ััะฐััะธ ััะตะฝะพะณะพ.
g-index
ะะปั ะดะฐะฝะฝะพะณะพ ะผะฝะพะถะตััะฒะฐ ััะฐัะตะน, ะพััะพััะธัะพะฒะฐะฝะฝะพะณะพ ะฒ ะฟะพััะดะบะต ัะฑัะฒะฐะฝะธั ะบะพะปะธัะตััะฒะฐ ัะธัะธัะพะฒะฐะฝะธะน, ะบะพัะพััะต ะฟะพะปััะธะปะธ ััะธ ััะฐััะธ, g-ะธะฝะดะตะบั ััะพ ะฝะฐะธะฑะพะปััะตะต ัะธัะปะพ, ัะฐะบะพะต ััะพ g ัะฐะผัั
ัะธัะธััะตะผัั
ััะฐัะตะน ะฟะพะปััะธะปะธ (ััะผะผะฐัะฝะพ) ะฝะต ะผะตะฝะตะต g2 ัะธัะธัะพะฒะฐะฝะธะน.
w-index
ะัะปะธ w ััะฐัะตะน ััะตะฝะพะณะพ ะธะผะตัั ะฝะต ะผะตะฝะตะต 10w ัะธัะธัะพะฒะฐะฝะธะน ะบะฐะถะดะฐั ะธ ะดััะณะธะต ััะฐััะธ ะผะตะฝััะต, ัะตะผ 10(w+1) ัะธัะธัะพะฒะฐะฝะธะน, ัะพ w-ะธะฝะดะตะบั ะธััะปะตะดะพะฒะฐัะตะปั ัะฐะฒะตะฝ w.
ะััะฝะฐะปั
|
1
2
3
4
5
|
|
|
Journal of Drug Delivery and Therapeutics
5 ะฟัะฑะปะธะบะฐัะธะน, 13.89%
|
|
|
Drug Delivery Letters
2 ะฟัะฑะปะธะบะฐัะธะธ, 5.56%
|
|
|
Nanoscience and Nanotechnology - Asia
2 ะฟัะฑะปะธะบะฐัะธะธ, 5.56%
|
|
|
Current Nanomedicine
2 ะฟัะฑะปะธะบะฐัะธะธ, 5.56%
|
|
|
Advances in Research
2 ะฟัะฑะปะธะบะฐัะธะธ, 5.56%
|
|
|
Recent Advances in Drug Delivery and Formulation
2 ะฟัะฑะปะธะบะฐัะธะธ, 5.56%
|
|
|
Journal of Pharmacognosy and Phytochemistry
2 ะฟัะฑะปะธะบะฐัะธะธ, 5.56%
|
|
|
iScience
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Journal of Microencapsulation
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Pharmaceutical Nanotechnology
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Current Rheumatology Reviews
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Journal of Drug Delivery Science and Technology
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Current Aging Science
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Journal of Pharmaceutical Research International
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
International Journal of Pharmaceutical Investigation
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Journal of Advances in Medicine and Medical Research
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Asian Journal of Research in Computer Science
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
International Research Journal of Modernization in Engineering Technology and Science
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
International Journal of Pharmaceutical Sciences and Medicine
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
International Journal of Computing and Artificial Intelligence
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
1
2
3
4
5
|
ะฆะธัะธััััะธะต ะถััะฝะฐะปั
ะฆะธัะธััะตะผัะต ะถััะฝะฐะปั
ะะทะดะฐัะตะปะธ
|
2
4
6
8
10
12
|
|
|
Bentham Science Publishers Ltd.
11 ะฟัะฑะปะธะบะฐัะธะน, 30.56%
|
|
|
Sciencedomain International
5 ะฟัะฑะปะธะบะฐัะธะน, 13.89%
|
|
|
Society of Pharmaceutical Tecnocrats
5 ะฟัะฑะปะธะบะฐัะธะน, 13.89%
|
|
|
Elsevier
2 ะฟัะฑะปะธะบะฐัะธะธ, 5.56%
|
|
|
AkiNik Publications
2 ะฟัะฑะปะธะบะฐัะธะธ, 5.56%
|
|
|
Taylor & Francis
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
MANUSCRIPT TECHNOMEDIA LLP
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Comprehensive Publications
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
Zain Publications
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
International Research Journal of Modernization in Engineering Technology and Science
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
2
4
6
8
10
12
|
ะัะณะฐะฝะธะทะฐัะธะธ ะธะท ะฟัะฑะปะธะบะฐัะธะน
|
5
10
15
20
25
|
|
|
ะัะณะฐะฝะธะทะฐัะธั ะฝะต ะพะฟัะตะดะตะปะตะฝะฐ
|
ะัะณะฐะฝะธะทะฐัะธั ะฝะต ะพะฟัะตะดะตะปะตะฝะฐ, 22, 61.11%
ะัะณะฐะฝะธะทะฐัะธั ะฝะต ะพะฟัะตะดะตะปะตะฝะฐ
22 ะฟัะฑะปะธะบะฐัะธะธ, 61.11%
|
|
ะฃะฝะธะฒะตััะธัะตัะฐ ะงะธัะบะฐัะฐ
7 ะฟัะฑะปะธะบะฐัะธะน, 19.44%
|
|
|
ะฃะฝะธะฒะตััะธัะตั ะ ะฐะดะถะฐััะฐะฝะฐ
4 ะฟัะฑะปะธะบะฐัะธะธ, 11.11%
|
|
|
ะฃะฝะธะฒะตััะธัะตั ะะะะก
4 ะฟัะฑะปะธะบะฐัะธะธ, 11.11%
|
|
|
ะะตะฝะดะถะฐะฑัะบะธะน ัะตั
ะฝะธัะตัะบะธะน ัะฝะธะฒะตััะธัะตั ะ. ะ. ะัะดะถัะฐะปะฐ
3 ะฟัะฑะปะธะบะฐัะธะธ, 8.33%
|
|
|
ะะถะฐะผะธั ะฅะฐะผะดะฐัะด
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
JSS ะะบะฐะดะตะผะธั ะฒัััะตะณะพ ะพะฑัะฐะทะพะฒะฐะฝะธั ะธ ะธััะปะตะดะพะฒะฐะฝะธะน
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
ะฃะฝะธะฒะตััะธัะตั ะะฐั
ะฐัะธัะธ ะะฐัะบะฐะฝะดะตัะฒะฐัะฐ, ะัะปะปะฐะฝะฐ
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
ะะฐััะฐัััะตััะบะฐั ะฑะพะปัะฝะธัะฐ ะพะฑัะตะณะพ ะฟัะพัะธะปั
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
ะะตะดะธัะธะฝัะบะฐั ัะบะพะปะฐ ะธะผะตะฝะธ ะงะฐะฝะฐ ะฟัะธ ะะฐััะฐัััะตััะบะพะผ ัะฝะธะฒะตััะธัะตัะต
1 ะฟัะฑะปะธะบะฐัะธั, 2.78%
|
|
|
5
10
15
20
25
|
ะกััะฐะฝั ะธะท ะฟัะฑะปะธะบะฐัะธะน
|
5
10
15
20
25
30
|
|
|
ะกััะฐะฝะฐ ะฝะต ะพะฟัะตะดะตะปะตะฝะฐ
|
ะกััะฐะฝะฐ ะฝะต ะพะฟัะตะดะตะปะตะฝะฐ, 28, 77.78%
ะกััะฐะฝะฐ ะฝะต ะพะฟัะตะดะตะปะตะฝะฐ
28 ะฟัะฑะปะธะบะฐัะธะน, 77.78%
|
|
ะะฝะดะธั
|
ะะฝะดะธั, 13, 36.11%
ะะฝะดะธั
13 ะฟัะฑะปะธะบะฐัะธะน, 36.11%
|
|
ะกะจะ
|
ะกะจะ, 5, 13.89%
ะกะจะ
5 ะฟัะฑะปะธะบะฐัะธะน, 13.89%
|
|
5
10
15
20
25
30
|
ะฆะธัะธััััะธะต ะพัะณะฐะฝะธะทะฐัะธะธ
ะฆะธัะธััััะธะต ัััะฐะฝั
|
5
10
15
20
25
30
35
|
|
|
ะกััะฐะฝะฐ ะฝะต ะพะฟัะตะดะตะปะตะฝะฐ
|
ะกััะฐะฝะฐ ะฝะต ะพะฟัะตะดะตะปะตะฝะฐ, 35, 36.46%
ะกััะฐะฝะฐ ะฝะต ะพะฟัะตะดะตะปะตะฝะฐ
35 ัะธัะธัะพะฒะฐะฝะธะน, 36.46%
|
|
ะะฝะดะธั
|
ะะฝะดะธั, 23, 23.96%
ะะฝะดะธั
23 ัะธัะธัะพะฒะฐะฝะธั, 23.96%
|
|
ะะธัะฐะน
|
ะะธัะฐะน, 6, 6.25%
ะะธัะฐะน
6 ัะธัะธัะพะฒะฐะฝะธะน, 6.25%
|
|
ะัะฐะปะธั
|
ะัะฐะปะธั, 5, 5.21%
ะัะฐะปะธั
5 ัะธัะธัะพะฒะฐะฝะธะน, 5.21%
|
|
ะกะจะ
|
ะกะจะ, 4, 4.17%
ะกะจะ
4 ัะธัะธัะพะฒะฐะฝะธั, 4.17%
|
|
ะขะฐะธะปะฐะฝะด
|
ะขะฐะธะปะฐะฝะด, 4, 4.17%
ะขะฐะธะปะฐะฝะด
4 ัะธัะธัะพะฒะฐะฝะธั, 4.17%
|
|
ะะฐะปะฐะนะทะธั
|
ะะฐะปะฐะนะทะธั, 3, 3.13%
ะะฐะปะฐะนะทะธั
3 ัะธัะธัะพะฒะฐะฝะธั, 3.13%
|
|
ะะฐะบะธััะฐะฝ
|
ะะฐะบะธััะฐะฝ, 3, 3.13%
ะะฐะบะธััะฐะฝ
3 ัะธัะธัะพะฒะฐะฝะธั, 3.13%
|
|
ะขัััะธั
|
ะขัััะธั, 3, 3.13%
ะขัััะธั
3 ัะธัะธัะพะฒะฐะฝะธั, 3.13%
|
|
ะะณะธะฟะตั
|
ะะณะธะฟะตั, 2, 2.08%
ะะณะธะฟะตั
2 ัะธัะธัะพะฒะฐะฝะธั, 2.08%
|
|
ะัะฐะฝ
|
ะัะฐะฝ, 2, 2.08%
ะัะฐะฝ
2 ัะธัะธัะพะฒะฐะฝะธั, 2.08%
|
|
ะกะฐัะดะพะฒัะบะฐั ะัะฐะฒะธั
|
ะกะฐัะดะพะฒัะบะฐั ะัะฐะฒะธั, 2, 2.08%
ะกะฐัะดะพะฒัะบะฐั ะัะฐะฒะธั
2 ัะธัะธัะพะฒะฐะฝะธั, 2.08%
|
|
ะะฒัััะฐะปะธั
|
ะะฒัััะฐะปะธั, 1, 1.04%
ะะฒัััะฐะปะธั
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะะฐะฝะฐ
|
ะะฐะฝะฐ, 1, 1.04%
ะะฐะฝะฐ
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะะพะฝะบะพะฝะณ (ะกะะ )
|
ะะพะฝะบะพะฝะณ (ะกะะ ), 1, 1.04%
ะะพะฝะบะพะฝะณ (ะกะะ )
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะะฝะดะพะฝะตะทะธั
|
ะะฝะดะพะฝะตะทะธั, 1, 1.04%
ะะฝะดะพะฝะตะทะธั
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะัะฐะบ
|
ะัะฐะบ, 1, 1.04%
ะัะฐะบ
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะัะปะฐะฝะดะธั
|
ะัะปะฐะฝะดะธั, 1, 1.04%
ะัะปะฐะฝะดะธั
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะัะฟะฐะฝะธั
|
ะัะฟะฐะฝะธั, 1, 1.04%
ะัะฟะฐะฝะธั
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะะพะปัะผะฑะธั
|
ะะพะปัะผะฑะธั, 1, 1.04%
ะะพะปัะผะฑะธั
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะะพะฒะฐั ะะตะปะฐะฝะดะธั
|
ะะพะฒะฐั ะะตะปะฐะฝะดะธั, 1, 1.04%
ะะพะฒะฐั ะะตะปะฐะฝะดะธั
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะะะญ
|
ะะะญ, 1, 1.04%
ะะะญ
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะะพะปััะฐ
|
ะะพะปััะฐ, 1, 1.04%
ะะพะปััะฐ
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะ ะตัะฟัะฑะปะธะบะฐ ะะพัะตั
|
ะ ะตัะฟัะฑะปะธะบะฐ ะะพัะตั, 1, 1.04%
ะ ะตัะฟัะฑะปะธะบะฐ ะะพัะตั
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะ ัะผัะฝะธั
|
ะ ัะผัะฝะธั, 1, 1.04%
ะ ัะผัะฝะธั
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะฃะทะฑะตะบะธััะฐะฝ
|
ะฃะทะฑะตะบะธััะฐะฝ, 1, 1.04%
ะฃะทะฑะตะบะธััะฐะฝ
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะญัะธะพะฟะธั
|
ะญัะธะพะฟะธั, 1, 1.04%
ะญัะธะพะฟะธั
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
ะฎะะ
|
ะฎะะ , 1, 1.04%
ะฎะะ
1 ัะธัะธัะพะฒะฐะฝะธะต, 1.04%
|
|
5
10
15
20
25
30
35
|
- ะั ะฝะต ััะธััะฒะฐะตะผ ะฟัะฑะปะธะบะฐัะธะธ, ั ะบะพัะพััั ะฝะตั DOI.
- ะกัะฐัะธััะธะบะฐ ะฟะตัะตััะธััะฒะฐะตััั ัะฐะท ะฒ ัััะบะธ.